Table 2 Patient characteristics
Total N = 330 | Mild N = 53 | Moderate I N = 157 | Moderate II N = 91 | Severe N = 29 | |
|---|---|---|---|---|---|
Age, median (IQR) | 53 (40–62) | 43 (30–55) | 52 (41–61) | 54 (48–63.5) | 57 (47–64) |
Sex, male (%) | 229 (69.4) | 32 (60.4) | 110 (70.1) | 64 (70.3) | 23 (79.3) |
Hospital days, median (IQR) | 10 (8–14) | 8 (7–10) | 9 (7–11) | 12 (10–15) | 17 (14–26) |
ICU stay, n (%) | 38 (11.5) | 0 | 0 | 9 (9.9) | 29 (100) |
Days of ICU stay, median (IQR) | 7 (3–13) | 0 | 0 | 3 (2–3) | 9 (5–16) |
Ventilator use, n (%) | 20 (6.1) | 0 | 0 | 0 | 20 (69.0) |
Days of ventilator use, median (IQR) | 10 (7–20) | 0 | 0 | 0 | 10 (7–20) |
Transfer from another hospital at admission, n (%) | 25 (7.6) | 0 | 3 (1.9) | 4 (4.4) | 18 (62.1) |
Treated with remdesivir, n (%) | 227 (68.8) | 5 (9.4) | 112 (71.3) | 84 (92.3) | 26 (89.7) |
In-hospital death, n (%) | 7 (2.1) | 0 | 0 | 2 (2.2) | 5 (17.2) |